Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
Naomi P. Visanji, Anthony E. Lang, Gábor G. Kovács
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
Zerui Wang, Katelyn Becker, Vincenzo Donadio, et al.
JAMA Neurology (2020) Vol. 78, Iss. 1, pp. 30-30
Open Access | Times Cited: 185
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology (2022) Vol. 214, pp. 102270-102270
Open Access | Times Cited: 154
Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
Lijun Dai, Li Zou, Lanxia Meng, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 2183-2201
Closed Access | Times Cited: 152
Disease modification and biomarker development in Parkinson disease
Alberto J. Espay, Lorraine V. Kalia, Ziv Gan‐Or, et al.
Neurology (2020) Vol. 94, Iss. 11, pp. 481-494
Open Access | Times Cited: 115
Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
D. Volc, Werner Poewe, Alexandra Kutzelnigg, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 7, pp. 591-600
Closed Access | Times Cited: 105
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
Daniela Perra, Matilde Bongianni, Giovanni Novi, et al.
Brain Communications (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 56
Neuroimmune contributions to Alzheimer’s disease: a focus on human data
Verena Haage, Philip L. De Jager
Molecular Psychiatry (2022) Vol. 27, Iss. 8, pp. 3164-3181
Open Access | Times Cited: 43
CSF-derived extracellular vesicles from patients with Parkinson’s disease induce symptoms and pathology
Shay Herman, Ruth Djaldetti, Brit Mollenhauer, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 209-224
Open Access | Times Cited: 41
Effect of citronellol on oxidative stress, neuroinflammation and autophagy pathways in an in vivo model of Parkinson's disease
Richard L. Jayaraj, Sheikh Azimullah, Khatija Parekh, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11434-e11434
Open Access | Times Cited: 37
The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
Wioletta Rozpędek‐Kamińska, Natalia Siwecka, Adam Wawrzynkiewicz, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2108-2108
Open Access | Times Cited: 67
Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils
Shailendra Dhakal, Courtney E. Wyant, Hannah E. George, et al.
Journal of Molecular Biology (2021) Vol. 433, Iss. 10, pp. 166953-166953
Open Access | Times Cited: 54
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study
Werner Poewe, D. Volc, Klaus Seppi, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 3, pp. 1079-1089
Open Access | Times Cited: 47
Autonomic Dysfunction in Sleep Disorders: From Neurobiological Basis to Potential Therapeutic Approaches
Hakseung Kim, Hee-Ra Jung, Jung Bin Kim, et al.
Journal of Clinical Neurology (2022) Vol. 18, Iss. 2, pp. 140-140
Open Access | Times Cited: 32
Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
Fabio Moda, Arianna Ciullini, Ilaria Linda Dellarole, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10, pp. 255-255
Open Access | Times Cited: 21
α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies
Noah J. Graves, Yann Gambin, Emma Sierecki
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12134-12134
Open Access | Times Cited: 16
Sex-specific biphasic alpha-synuclein response and alterations of interneurons in a COVID-19 hamster model
Cara Sophie Schreiber, Ivo Wiesweg, Stephanie Stanelle-Bertram, et al.
EBioMedicine (2024) Vol. 105, pp. 105191-105191
Open Access | Times Cited: 7
CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders
Chloe Anastassiadis, Iván Martínez-Valbuena, Anna Vasilevskaya, et al.
Neurology (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 7
The impact of hUC MSC–derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity
Farhang Aliakbari, Kimia Marzookian, Soha Parsafar, et al.
Science Advances (2024) Vol. 10, Iss. 14
Open Access | Times Cited: 6
Seven Solutions for Neuroprotection in Parkinson's Disease
David Devos, Étienne C. Hirsch, Richard Wyse
Movement Disorders (2020) Vol. 36, Iss. 2, pp. 306-316
Open Access | Times Cited: 42
Biomarkers in Parkinson’s Disease
Andrei Surguchov
Neuromethods (2021), pp. 155-180
Closed Access | Times Cited: 36
Single-Particle Resolution of Copper-Associated Annular α-Synuclein Oligomers Reveals Potential Therapeutic Targets of Neurodegeneration
Olena Synhaivska, Shayon Bhattacharya, Silvia Campioni, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 9, pp. 1410-1421
Open Access | Times Cited: 25
Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
Mie Kristine Just, Hjalte Gram, Vasileios Theologidis, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 22
Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment
Richard Smith, Hanna Hovren, Robert Bowser, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 4
Open Access | Times Cited: 5
The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
Angenelle Eve Rosal, Sarah L. Martin, Antonio P. Strafella
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Genetic architecture of common non-Alzheimer’s disease dementias
Rita Guerreiro, Elizabeth Gibbons, Miguel Tábuas‐Pereira, et al.
Neurobiology of Disease (2020) Vol. 142, pp. 104946-104946
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top